Not exact matches
By treating patients faster and keeping them well,
advanced pharmaceuticals lower health
care costs elsewhere.
Recognized as a standard of excellence in health
care packaging, this
advanced material is used in virtually every form of sterile medical packaging, as well as a wide variety of
pharmaceutical packaging applications.
Since those
advances, we've become an innovative supplier of case packers for the food,
pharmaceutical, and personal
care industries.
Existing regional strengths include the aerospace and agrifood industries;
advanced manufacturing; creative and cultural enterprises such as design, music, and entertainment; sustainable transportation in the automotive and boating industries; and health
care, including
pharmaceuticals, biotechnology, and medical device development.
The University of Leicester has secured funding from the Medical Research Council (MRC) Proximity to Discovery scheme to support engagement between academic scientists and industry partners to drive biomedical research into «real world»
advances in health
care, bio-medical and
pharmaceutical sectors.
Improvements in the speed and cost of DNA synthesis are enabling scientists to design and synthesize modified bacterial chromosomes that can be used in the production of
advanced biofuels, bio-products, renewable chemicals, bio-based specialty chemicals (
pharmaceutical intermediates, fine chemicals, food ingredients), and in the health
care sector as well.
Risks and uncertainties include but are not limited to, general industry conditions and competition; general economic factors, including interest rate and currency exchange rate fluctuations; the impact of
pharmaceutical industry regulation and health
care legislation in the United States and internationally; global trends toward health
care cost containment; technological
advances, new products and patents attained by competitors; challenges inherent in new product development, including obtaining regulatory approval; Merck's ability to accurately predict future market conditions; manufacturing difficulties or delays; financial instability of international economies and sovereign risk; dependence on the effectiveness of Merck's patents and other protections for innovative products; and the exposure to litigation, including patent litigation, and / or regulatory actions.
Risks and uncertainties include but are not limited to, general industry conditions and competition; general economic factors, including interest rate and currency exchange rate fluctuations; the impact of
pharmaceutical industry regulation and health
care legislation in the United States and internationally; global trends toward health
care cost containment; technological
advances, new products and patents attained by competitors; challenges inherent in new product development, including obtaining regulatory approval; the company's ability to accurately predict future market conditions; manufacturing difficulties or delays; financial instability of international economies and sovereign risk; dependence on the effectiveness of the company's patents and other protections for innovative products; and the exposure to litigation, including patent litigation, and / or regulatory actions.
supporting
advances in human biotechnology;
pharmaceuticals; and health
care policy outside the realm of IT.
This one - credit
advanced legal research seminar will introduce students to specific sources and strategies for researching health and medical legal topics, including the right to health
care,
pharmaceutical and medical device regulation, Stark and anti-trust laws as applied to the health
care industry, medical malpractice and standards of
care, and medical ethics and experimentation.
Foley Hoag, a leading law firm with offices in Boston, Washington, D.C., New York and Paris, represents biotechnology,
pharmaceutical, medical device,
advanced diagnostic, and health
care companies regulated by the Food and Drug Administration (FDA).
NPTA will provide an active voice, always representative of our members, to help
advance the healthcare profession and the standard of
pharmaceutical care given to patients.
This includes: (1) Involvement with multiple drug distribution functions (inclusive of computerized physician order entry and / or prospective review and verification of physicians» orders, IV admixture preparation, etc.)(2) Defined clinical activities to optimize therapeutic outcomes under the guidance of the departmental and corporate directives (which include active communication with physicians, nurses, and other healthcare staff about the need to clarify and / or change an order along with documentation of intervention outcomes)(3) Educational activities with pharmacist colleagues and other health
care professionals (e.g., physicians, nurses, etc.) to maintain and
advance clinical competencies (4) Supervise and provide oversight and direction of technicians» drug preparation and distribution activities to assure safe and expedient provision of
pharmaceutical care to patients and staff.
As a certified SAS
advanced programmer and SAS Clinical Trials Programmer, I am looking for a statistical programmer position in the
pharmaceutical industry or health
care field.